MediPharm Labs

(OTC: MEDIF)
Healthcare  |  Drug Manufacturers—Specialty & Generic
0.87 -0.008 -0.91%
Stock Price | July 15, 2020, 3:45 p.m.
1 Follower
Bid: 0.8684
Ask: 0.8861
Prev. Close: 0.87795
52 Week Low: 0.7898
52 Week High: 1.7
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

MediPharm Labs Corp has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulation without first receiving a cannabis cultivation license. The focus on cannabis concentrates from current Good Manufacturing Practices and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to produce purified, pharmaceutical-grade cannabis oil and concentrates for derivative products. The company has invested in the research-driven team, technology, downstream extraction methodologies and purpose-built facilities to deliver safe and precisely-dosed cannabis products to patients and consumers.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 07/10/20

8 Comments
6 days ago

Premium Assessing Focus List Prospects Over the Balance of 2020

4 Comments
1 week ago

Premium Cannabis Stocks Review - Weekend Edition 07/06/20

4 Comments
1 week ago

Premium Cannabis Stocks Review - Pre-Market Edition 06/30/20

2 Comments
2 weeks ago
2 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 06/29/20

18 Comments
2 weeks ago

Premium Weekly Review 06/26/20

2 weeks ago

Premium Cannabis Stocks Review - Pre-Market Edition 06/23/20

3 Comments
3 weeks ago

Premium Cannabis Stocks Review - Weekend Edition 06/22/20

21 Comments
3 weeks ago

Premium Weekly Review 06/19/20

3 weeks ago